A Phase 4 interventional study of Lidocaine jelly application and Normal saline application in Sore Throat, sponsored by Keimyung University Dongsan Medical Center. Status unknown. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2016-11-02.
Sponsored by Keimyung University Dongsan Medical Center · Phase 4, Interventional, and Prevention
Postoperative sore throat is a complication after general anesthesia requiring endotracheal intubation. The investigators will evaluate the efficacy of lidocaine jelly application on the endotracheal tube with taper-shaped cuff regarding postoperative sore throat.
252 studies on the registry are indexed under Pharyngitis; 36 are open to participants now.
This study's planned enrollment of 210 is above the median of 144 across 209 interventional studies indexed under Pharyngitis.
Browse Pharyngitis studies →Keimyung University Dongsan Medical Center is the lead sponsor of 81 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Normal saline will be applied to the endotracheal tube.
Drug: Normal saline application
Lidocaine jelly will be applied to the endotracheal tube.
Drug: Lidocaine jelly application
Number of participants with sore throat
Time frame: At 24 hr
Number of participants with sore throat
Time frame: At 1, 6, and 12 hr
Number of participants with hoarseness
Time frame: At 1, 6, 12 and 24 hr
Number of participants with throat numbness
Time frame: At 1, 6, 12 and 24 hr
Number of participants with nausea
Time frame: At 1, 6, 12 and 24 hr
Number of participants with vomiting
Time frame: At 1, 6, 12 and 24 hr
Number of participants with cough
Time frame: At 1, 6, 12 and 24 hr
Number of participants with dry mouth
Time frame: At 1, 6, 12 and 24 hr
Number of participants with additional pain medication
Time frame: At 24 hr
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Oct 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Keimyung University Dongsan Medical Center